M1 Kliniken AG · ISIN: DE000A0STSQ8 · EQS - Company News

M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets

  M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million Beauty segment growth driver with sales +33.5% to EUR 71.02 million EBIT in the Beauty segment +30.4% to EUR 16.26 million Medium-term target confirmed: World's leading private provider of beauty treatments                             Berlin, 19.11.2024 –M1 Kliniken AG (ISIN: DE000A0STSQ8) ca...

XETR:M12 Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News M1 Kliniken AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (21)
Directors Dealings (8)
Short Selling (DE) (0)
Short Selling (UK) (0)
19 November 2024 08:15AM
M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
DE000A0STSQ8
  M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million Beauty segment growth driver with sales +33.5% to EUR 71.02 million EBIT in the Beauty segment +30.4% to EUR 16.26 million Medium-term target c...
M1 Kliniken AG
About the publication
03 September 2024 08:45AM
M1 Kliniken AG also grows significantly in the first half of 2024
DE000A0STSQ8
  Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024   Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million Earnings per share increased from EUR 0.17 to EUR 0.53 Beauty segment: sales +30.6% and EBIT +24.3% Profitable growth to be continued   Berlin, 03.09.2024 –...
M1 Kliniken AG
About the publication
21 June 2024 12:47PM
Management Board confirms growth targets
DE000A0STSQ8
M1 Kliniken AG: Management Board confirms growth targets Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG. Attila Strauss emphasis...
M1 Kliniken AG
About the publication
21 June 2024 12:47PM
Management Board confirms growth targets
DE000A0STSQ8
M1 Kliniken AG: Management Board confirms growth targets Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN: DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a tangible stake of over 2.3% in M1 Kliniken AG. Attila Strauss emphasis...
M1 Kliniken AG
About the publication
11 June 2024 04:38PM
M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
DE000A0STSQ8
 M1 Kliniken announces change in the Management Board and confirms long-term growth strategy Berlin, 11 June 2024 - Kilian Brenske, member of the Management Board since 2022, has asked the Supervisory Board to terminate his position on the Management Board for private reasons. The areas of national and international expansion, marketing, purchasin...
M1 Kliniken AG
About the publication
06 June 2024 08:30AM
EBIT +70% in the first quarter of 2024
DE000A0STSQ8
  M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024   Group sales increase by 9.6% to EUR 84.7 million in Q1 2024 Growth driver Beauty segment: sales +18.2% and EBIT +50% Strong operating performance should continue for the rest of the year   Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A...
M1 Kliniken AG
About the publication
06 June 2024 08:30AM
EBIT +70% in the first quarter of 2024
DE000A0STSQ8
  M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024   Group sales increase by 9.6% to EUR 84.7 million in Q1 2024 Growth driver Beauty segment: sales +18.2% and EBIT +50% Strong operating performance should continue for the rest of the year   Berlin, June 6, 2024 – M1 Kliniken AG (ISIN: DE000A...
M1 Kliniken AG
About the publication
23 May 2024 08:30AM
Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
DE000A0STSQ8
  M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics    Group sales increase by 10.9% to € 316.3 million in 2023 Highly profitable beauty segment drives growth with an increase of 17.6% to EUR 70.8 million Consolidated net profit (after minority interests) improved from E...
M1 Kliniken AG
About the publication
23 May 2024 08:30AM
Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics
DE000A0STSQ8
  M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics    Group sales increase by 10.9% to € 316.3 million in 2023 Highly profitable beauty segment drives growth with an increase of 17.6% to EUR 70.8 million Consolidated net profit (after minority interests) improved from E...
M1 Kliniken AG
About the publication
07 May 2024 04:28PM
Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share
DE000A0STSQ8
Berlin, 07.05.2024 – The Supervisory Board of M1 Kliniken AG (ISIN:DE000A0STSQ8) today approved the annual financial statements and the consolidated financial statements of the financial year 2023 presented by the Management Board in accordance with Sections 171, 172 AktG. The annual financial statements are thus adopted in accordance with Section ...
M1 Kliniken AG
About the publication
26 April 2024 11:06AM
M1 Kliniken AG decides to start share buyback
DE000A0STSQ8
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014   M1 Kliniken AG decides to start share buyback Berlin, 26.04.2024 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,000,000 shares of the Company in a maximum total volume of EUR 12,600,000.00 (excluding incidental acquisition cos...
M1 Kliniken AG
About the publication
18 April 2024 08:34AM
M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million
DE000A0STSQ8
M1 Kliniken AG publishes preliminary figures for financial year 2023: M1 continues to grow - sales growth of over 10% to € 316,3 million; EBIT increases by 68% to € 15.7 million and the Group's equity increases to € 143.7 million.                Strong sales growth of 18% in the Beauty segment from € 60.2 million to € 70.8 million. Four locatio...
M1 Kliniken AG
About the publication
16 February 2024 03:10PM
Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024
DE000A0STSQ8
M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024 Management is open to interested parties Valuations in the peer group of up to 30 times the annual EBITDA M1 Kliniken AG expects EBITDA of over EUR 27 million in 2024 Berlin, 16 February 2024 - M1 Kliniken AG (ISIN: DE000A0STSQ8) has built...
M1 Kliniken AG
About the publication
05 February 2024 01:00PM
Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard
DE000A0STSQ8
The two members of the Management Board of M1 Kliniken AG, Mr Attila Strauss and Mr Kilian Brenske, acquired a total of 1.5 million shares in the company from MPH Health Care AG on 2 February 2024. The Co-CEOs justify the share purchase with their confidence in the long-term growth prospects of M1 Kliniken AG and the desire to participate even more...
M1 Kliniken AG
About the publication
22 January 2024 10:26AM
30 pm
DE000A0STSQ8
Invitation to the virtual AlsterResearch Healthcare Pop-Up Conferenceon 23 January 2024 at 1:30 pm As part of the AlsterResearch Healthcare Pop-Up Conference, we cordially invite you to our virtual roundtable on Tuesday, 23 January 2024 at 13:30 (CET). Attila Strauss, Co-CEO of M1 Kliniken AG, and Kilian Brenske, Co-CEO of M1 Kliniken AG, will give...
M1 Kliniken AG
About the publication
24 November 2023 08:48AM
M1 Kliniken AG Acquires Online Pharmacy and Secures Long-Term Procurement Advantages
DE000A0STSQ8
M1 Kliniken AG Acquires Online Pharmacy and Secures Long-Term Procurement Advantages Increasing value creation and margin improvement, as well as ensuring the supply of aesthetic pharmaceuticals to medical treatment centers through the acquisition of a Dutch online pharmacy. Berlin, November 24, 2023 – By acquiring the German Nutri Care GmbH and ...
M1 Kliniken AG
About the publication
16 November 2023 08:56AM
Further strong growth and doubling of the operating result
DE000A0STSQ8
M1 Kliniken AG publishes figures for the third quarter 2023: Further strong growth and doubling of the operating result       Group sales increase by over 10% to EUR 236.6 million in the first nine months of the 2023 financial year (previous year: EUR 214.2 million).   Group EBITDA increases by over 55% from EUR 10.9 million to EUR 16.9 million. ...
M1 Kliniken AG
About the publication
01 September 2023 08:50AM
Market leader for beauty medicine in Germany opens up in the 9th foreign market and prepares market entry in the USA
DE000A0STSQ8
M1 Kliniken AG: Market leader for beauty medicine in Germany opens up in the 9th foreign market and prepares market entry in the USA   20th Location outside Germany opened in Bucharest, Romania Break-even expected for foreign locations within the next 12 months Subsidiary established in the USA: Market entry into the world's largest market for...
M1 Kliniken AG
About the publication
31 August 2023 11:50AM
DE000A0STSQ8
M1 Kliniken AG publishes figures for the first half year 2023: Further growth and disproportionate increase in operating result.   Group revenue increases by around 9% to EUR 150.8 million in the first half of 2023 (previous year: EUR 138.7 million)    Group EBIT increases by over 60 % to EUR 7.3 million (previous year: EUR 4.5 million)  Beaut...
M1 Kliniken AG
About the publication
31 May 2023 04:52PM
Strong growth and disproportionate increase in operating result
DE000A0STSQ8
M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result.    Group revenue rises by 21% to EUR 76.8 million Group EBITDA amounts to EUR 5.3 million (previous year: EUR 4.2 million); EBIT amounts to EUR 4.0 million (previous year: EUR 2.8 million) Beauty segment: sales increase of more than 50% ...
M1 Kliniken AG
About the publication
31 May 2023 04:52PM
M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result
DE000A0STSQ8
M1 Kliniken AG publishes Q1 figures 2023: Strong growth and disproportionate increase in operating result.    Group revenue rises by 21% to EUR 76.8 million Group EBITDA amounts to EUR 5.3 million (previous year: EUR 4.2 million); EBIT amounts to EUR 4.0 million (previous year: EUR 2.8 million) Beauty segment: sales increase of more than 50% ...
M1 Kliniken AG
About the publication
20 April 2023 12:59PM
M1 Kliniken AG decides to start share buyback
DE000A0STSQ8
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014  M1 Kliniken AG decides to start share buyback Berlin, 20 April 2023 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,500,000 shares of the Company in a maximum total volume of EUR 10,800,000.00 (excluding incidental acquisition co...
M1 Kliniken AG
About the publication
20 April 2023 12:59PM
M1 Kliniken AG decides to start share buyback
DE000A0STSQ8
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014  M1 Kliniken AG decides to start share buyback Berlin, 20 April 2023 - The Management Board of M1 Kliniken AG today resolved to repurchase up to 1,500,000 shares of the Company in a maximum total volume of EUR 10,800,000.00 (excluding incidental acquisition co...
M1 Kliniken AG
About the publication
20 April 2023 09:00AM
M1 Kliniken AG publishes preliminary figures for financial year 2022
DE000A0STSQ8
M1 Kliniken AG publishes preliminary figures for financial year 2022: Profitable revenue growth in the Beauty segment of more than 14%; increase in EBIT margin in the Beauty segment from 9.8% to around 12%; Group equity rises to €143.1 million; free cash flow of €19.0 million.                Strong sales growth in the Beauty segment from €52.8 ...
M1 Kliniken AG
About the publication
20 April 2023 09:00AM
M1 Kliniken AG publishes preliminary figures for financial year 2022
DE000A0STSQ8
M1 Kliniken AG publishes preliminary figures for financial year 2022: Profitable revenue growth in the Beauty segment of more than 14%; increase in EBIT margin in the Beauty segment from 9.8% to around 12%; Group equity rises to €143.1 million; free cash flow of €19.0 million.                Strong sales growth in the Beauty segment from €52.8 ...
M1 Kliniken AG
About the publication
24 November 2022 03:46PM
Expansion of the Management Board of M1 Kliniken AG
DE000A0STSQ8
Expansion of the Management Board of M1 Kliniken AG Berlin, 24.11.2022 - The Supervisory Board of M1 Kliniken AG today appointed Mr. Attila Strauss to the Management Board of M1 Kliniken AG with immediate effect. Mr. Strauss has already been a member of the Management Board of HAEMATO AG since April 1, 2022 and has contributed to a significant co...
M1 Kliniken AG
About the publication
24 November 2022 03:46PM
Expansion of the Management Board of M1 Kliniken AG
DE000A0STSQ8
Expansion of the Management Board of M1 Kliniken AG Berlin, 24.11.2022 - The Supervisory Board of M1 Kliniken AG today appointed Mr. Attila Strauss to the Management Board of M1 Kliniken AG with immediate effect. Mr. Strauss has already been a member of the Management Board of HAEMATO AG since April 1, 2022 and has contributed to a significant co...
M1 Kliniken AG
About the publication
15 November 2022 06:31PM
Expansion of the Management Board of M1 Kliniken AG
DE000A0STSQ8
Expansion of the Management Board of M1 Kliniken AG Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG. Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all...
M1 Kliniken AG
About the publication
15 November 2022 06:31PM
Expansion of the Management Board of M1 Kliniken AG
DE000A0STSQ8
Expansion of the Management Board of M1 Kliniken AG Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG. Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all...
M1 Kliniken AG
About the publication
14 November 2022 09:30AM
Group continues the expansion course with development of a new country market
DE000A0STSQ8
M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market Group turnover decreases to EUR 214 million (EUR 236 million as of Q3-2021) Group EBITDA amounts to EUR 10.9 million (previous year: EUR 12.0 million); EBIT amounts to EUR 6.5 million (previous year: EUR 7.8 million) Beauty...
M1 Kliniken AG
About the publication
14 November 2022 09:30AM
M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
DE000A0STSQ8
M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market Group turnover decreases to EUR 214 million (EUR 236 million as of Q3-2021) Group EBITDA amounts to EUR 10.9 million (previous year: EUR 12.0 million); EBIT amounts to EUR 6.5 million (previous year: EUR 7.8 million) Beauty...
M1 Kliniken AG
About the publication
17 August 2022 09:30AM
M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate
DE000A0STSQ8
M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate Group revenue falls to just under EUR 139 million (EUR 165 million in H1-2021) Group EBITDA amounts to EUR 7.4 million (previous year: EUR 9.9 million); EBIT amounts to EUR 4.5 million (previous year: EUR 7.1 million) Beauty...
M1 Kliniken AG
About the publication
17 August 2022 09:30AM
positive business development despite cooling of general consumer climate
DE000A0STSQ8
M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate Group revenue falls to just under EUR 139 million (EUR 165 million in H1-2021) Group EBITDA amounts to EUR 7.4 million (previous year: EUR 9.9 million); EBIT amounts to EUR 4.5 million (previous year: EUR 7.1 million) Beauty...
M1 Kliniken AG
About the publication
23 May 2022 09:00AM
M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DE000A0STSQ8
M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment - Group turnover falls to EUR 63.5 million (EUR 80.8 million in Q1-2021) - Group EBITDA amounts to EUR 4.2 million (previous year: EUR 4.0 million); EBIT amounts to EUR 2.8 million (previous year: EUR 2.6 million) - Beauty: In...
M1 Kliniken AG
About the publication
04 May 2022 09:00AM
M1 Kliniken AG: Supervisory Board adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March
DE000A0STSQ8
Supervisory Board of M1 Kliniken AG adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March - Supervisory Board adopts the 2021 annual financial statements of M1 Kliniken AG, which have been audited with unqualified audit opinions - Turnove...
M1 Kliniken AG
About the publication
30 March 2022 10:45AM
M1 Kliniken AG publishes preliminary figures for financial year 2021: revenue rises to € 315 million; pre-tax profit amounts to € 14.4 million
DE000A0STSQ8
M1 Kliniken AG publishes preliminary figures for financial year 2021: revenue rises to € 315 million; pre-tax profit amounts to € 14.4 million - Group turnover increases by almost 100 % to 314.6 million euros - Group operating result (EBIT) almost tripled to €12.1 million (€4.4 million in 2020). Consensus of the capital market exceeded - Pre-t...
M1 Kliniken AG
About the publication
03 December 2021 07:00AM
M1 Kliniken AG continues successful development in Q4 2021
DE000A0STSQ8
M1 Kliniken AG continues successful development in Q4 2021 Average daily sales in November 2021 in the German practice network again at record level All specialist centres open With four more openings in Germany and Australia, M1 will operate a total of 47 specialty centres by year-end 2021 Berlin, 3.12.2021 - M1 Kliniken AG (ISIN: DE000A0STSQ8)...
M1 Kliniken AG
About the publication
18 November 2021 07:00AM
M1 Kliniken AG announces financials for Q3-2021: forecasts confirmed after good development of treatment and business figures
DE000A0STSQ8
M1 Kliniken AG announces financials for Q3-2021: forecasts confirmed after good development of treatment and business figures - Group revenue rises to EUR 237 million (EUR 82 million in Q3-2020) - Beauty: treatment numbers at high level; record revenue in German practice network in October 2021; no negative impact from rising incidence rate of th...
M1 Kliniken AG
About the publication
20 September 2021 04:01PM
M1 Kliniken AG continues growth course
DE000A0STSQ8
M1 Kliniken AG continues growth course - Significant expansion of site capacities in Germany and internationally - Sales in the "Beauty" segment well above the previous year's figures. Expected annual sales of over EUR 50 million in the Beauty segment in 2021 Berlin, 20.09.2021 - M1 Kliniken AG (ISIN: DE000A0STSQ8) sustainably continues its gro...
M1 Kliniken AG
About the publication
25 August 2021 02:30PM
M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued Corona burdens
DE000A0STSQ8
M1 Kliniken AG publishes figures for the 1st half of 2021: stable business development despite continued Corona burdens - Group revenue rises to just under EUR 165 million (EUR 37 million in H1-2020) - Consolidated EBITDA amounts to EUR 9.9 million (previous year: EUR 1.7 million); EBIT amounts to EUR 7.1 million (previous year: EUR -0.05 million...
M1 Kliniken AG
About the publication
16 July 2021 09:24AM
M1 Kliniken AG successfully held its Annual General Meeting 2021
DE000A0STSQ8
M1 Kliniken AG successfully held its Annual General Meeting 2021 Berlin, 16 July 2021 - M1 Kliniken AG (ISIN: DE000A0STSQ8) successfully held its Annual General Meeting 2021 on 14 July 2021. After the Corona-related restrictions of the previous year, the Management Board is confident about the development of the company in the current financial ...
M1 Kliniken AG
About the publication
01 June 2021 08:30AM
M1 Kliniken AG publishes figures for the 1st quarter of 2021: successful start to 2021 with significant increase in revenues and earnings in both business segments
DE000A0STSQ8
M1 Kliniken AG publishes figures for the 1st quarter of 2021: successful start to 2021 with significant increase in revenues and earnings in both business segments Group turnover rises to almost EUR 81 million (EUR 23 million in Q1-2020) Group EBITDA amounts to EUR 4.0 million (previous year: EUR 1.4 million); EBIT amounts to EUR 2.6 million (pre...
M1 Kliniken AG
About the publication
27 April 2021 11:00AM
M1 Kliniken AG publishes preliminary figures for the 2020 financial year: revenue rises to € 160 million; net profit for the year amounts to € 7.4 million.
DE000A0STSQ8
M1 Kliniken AG publishes preliminary figures for the 2020 financial year: revenue rises to € 160 million; net profit for the year amounts to € 7.4 million - Group turnover rises by more than 100 % to 159.6 million euros - Consolidated net income falls by 24 % to 7.4 million euros due to the pandemic - Outlook for 2021: restart of expansion and ...
M1 Kliniken AG
About the publication
15 December 2020 03:10PM
M1 Kliniken AG disposes subsidiary 'M1 Aesthetics GmbH' to HAEMATO AG - Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG AG:
DE000A0STSQ8
M1 Kliniken AG disposes subsidiary "M1 Aesthetics GmbH" to HAEMATO AG - Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG Berlin, 15.12.2020 - M1 Kliniken AG and HAEMATO AG today signed a contract for the acquisition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M...
M1 Kliniken AG
About the publication
15 December 2020 03:00PM
M1 Kliniken AG disposes subsidiary 'M1 Aesthetics GmbH' to HAEMATO AG - Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG
DE000A0STSQ8
M1 Kliniken AG disposes subsidiary "M1 Aesthetics GmbH" to HAEMATO AG - Transfer of the holding of the company within the scope of a capital increase in kind of HAEMATO AG Berlin, 15.12.2020 - M1 Kliniken AG and HAEMATO AG today signed a contract for the acquisition of all shares in M1 Aesthetics GmbH by HAEMATO AG. M1 Kliniken AG will contribute M...
M1 Kliniken AG
About the publication
30 November 2020 03:30PM
M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG - Group
DE000A0STSQ8
M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG - Group Berlin, 30.11.2020 - M1 Kliniken AG announces that as of today Mr. Patrick Brenske will join the Management Board of HAEMATO AG. At the same time, Mr. Brenske will...
M1 Kliniken AG
About the publication
04 November 2020 08:00AM
M1 Kliniken AG: Number of treatments increase by almost 20 % in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities.
DE000A0STSQ8
M1 Kliniken AG: Number of treatments increase by almost 20% in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities. Berlin, 4.11.2020 - In contrast to the worsening pandemic situation, M1 Kliniken AG continues to record strong demand. The number of injection treatments and surgical treatments performed in the German ...
M1 Kliniken AG
About the publication
26 August 2020 09:45AM
M1 Kliniken AG announces its financials for the 1st half of 2020
DE000A0STSQ8
M1 Kliniken AG announces its financials for the 1st half of 2020 - continuation of profitable growth despite corona-related closure - Group revenues decrease by only 12 % to 29.1 million Euro despite loss of about 1/3 of treatment days - Consolidated net income of 2.0 million Euro - High utilization of the specialized centers after resumption of...
M1 Kliniken AG
About the publication
More M1 Kliniken AG related information
Type Total Last Made by Go to
Corporate Research 21 17th December 2024 EQS Group AG Corporate Research
Directors Dealings 8 21st June 2024 Strauss, Attila DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN